EPILEPTIC ENCEPHALOPATHY
Clinical trials for EPILEPTIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new EPILEPTIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for EPILEPTIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Extended safety check for promising seizure drug shows promise
Disease control CompletedThis study followed 412 patients with rare, severe seizure disorders like Dravet and Lennox-Gastaut syndromes to check the long-term safety of an add-on medication called ZX008 (fenfluramine). Participants had already taken the drug in earlier studies and continued it here to mon…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Apr 04, 2026 03:05 UTC
-
New hope for kids with severe Sleep-Related epilepsy
Disease control CompletedThis study tested whether a new drug called NBI-827104 could help children with a rare and severe form of epilepsy that causes continuous abnormal brain waves during sleep. 24 children participated, taking the drug or a placebo daily for 13 weeks. The main goal was to see if the …
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test Easier-to-Swallow liquid for severe childhood epilepsy
Knowledge-focused CompletedThis study tested how the body absorbs a new liquid form of the drug stiripentol, used for a severe form of childhood epilepsy called Dravet syndrome. Researchers compared it to the standard capsule form in 24 healthy adults to see if they work similarly. The goal is to provide a…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC